Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Crescent Biopharma Stock Price, Quotes and Forecasts | NASDAQ:CBIO | Benzinga

Q: What sector and industry does Crescent Biopharma (CBIO) operate in?

Crescent Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Crescent Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CBIO.

Open	$11.06
Close	$14.62
Volume / Avg.	97.59K / 20.30K
Day Range	$11.06 - $15.81
52 Wk Range	12.92 - 19.32
Market Cap	$280.80M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	70
Short Interest	-
Days to Cover	1

Recent News

US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity

U.S. futures were higher on Wednesday as oil futures tumbled after Donald Trump called for an "Unconditional Surrender" by Iran late Tuesday.

Rishabh Mishra

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.7

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$11.06
Close	$14.62
Volume / Avg.	97.59K / 20.30K
Day Range	$11.06 - $15.81
52 Wk Range	12.92 - 19.32
Market Cap	$280.80M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	70
Short Interest	-
Days to Cover	1

About Crescent Biopharma Inc

Sector

Health Care

Industry

Biotechnology

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Crescent Biopharma (CBIO) stock?

You can purchase shares of Crescent Biopharma (NASDAQ:CBIO) through any online brokerage.

View our list of the best stock brokerages

Who are Crescent Biopharma (CBIO) competitors?

Other companies in Crescent Biopharma’s space includes: Inozyme Pharma (NASDAQ:INZY), Tevogen Bio Holdings (NASDAQ:TVGN), Monte Rosa Therapeutics (NASDAQ:GLUE), Olema Pharmaceuticals (NASDAQ:OLMA) and Neurogene (NASDAQ:NGNE).

What is the forecast, or price target, for Crescent Biopharma (CBIO) stock?

Crescent Biopharma has a consensus price target of $22.00.

What is the current price for Crescent Biopharma (CBIO)?

The stock price for Crescent Biopharma (NASDAQ: CBIO) is $14.4 last updated June 18, 2025 at 6:35 PM EDT.

Does Crescent Biopharma (CBIO) pay a dividend?

There are no upcoming dividends for Crescent Biopharma.

When is Crescent Biopharma (NASDAQ:CBIO) reporting earnings?

Crescent Biopharma’s Q3 earnings are confirmed for Thursday, October 26, 2023.

Is Crescent Biopharma (CBIO) going to split?

There is no upcoming split for Crescent Biopharma.

What sector and industry does Crescent Biopharma (CBIO) operate in?

Crescent Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Crescent Biopharma Stock Price, Quotes and Forecasts

Crescent Biopharma (CBIO) Forecast